• Users Online: 223
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2022  |  Volume : 24  |  Issue : 3  |  Page : 143-146

The prevalence, duration, and outcome of anosmia in COVID-19 subjects admitted to two tertiary care hospitals in Saudi Arabia


1 Department of Otolaryngology-Head and Neck Surgery, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia
2 Department of Otolaryngology-Head and Neck Surgery, King Faisal Specialist Hospital and Research Centre, Jeddah; Department of ORL-HNS, Collage of Medicine, Umm Al-Qura University, Mecca, Saudi Arabia
3 Department of Otolaryngology-Head and Neck Surgery, King Faisal Specialist Hospital and Research Centre; Department of ORL-HNS, Collage of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
4 Department of ORL-HNS, Collage of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
5 Department of ORL-HNS, Collage of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
6 Department of Pediatrics, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Saudi Arabia
7 Department of ORL-HNS, Ohud Hospital, Medina, Saudi Arabia

Correspondence Address:
Dr. Samiha F Khayyat
King Abdulaziz Medical City, National Guard Health Affairs, Jeddah
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/sjoh.sjoh_37_22

Rights and Permissions

Objectives: The objective is to investigate anosmia in patients with COVID-19 in tertiary care hospitals in two major cities in the Kingdom of Saudi Arabia to determine its prevalence, clinical characteristics, duration, and outcome. Methods: A retrospective study on COVID-19 patients who are admitted to our tertiary care hospital between May and December 2020. The inclusion criteria were all patients who are admitted to our tertiary care hospital with a confirmed diagnosis of COVID-19 in this study, we enrolled 545 patients for this study. Results: Of the 545 contacted subjects, 277 (50.82%) answered, whereas 268 were excluded, 26 (4.8%) of which passed away. One hundred and nineteen (42.96%) subjects were female whereas 158 (57.04%) were male. The mean age was 42.81 ± 16.76 standard deviation. About 162 (58.47%) of the 277 who completed the interview had anosmia; moreover, anosmia was grouped into transient and persistent anosmia. It was persistent in 15 subjects (5.4%) and transient in 147 subjects (94.6%); the range duration of transient anosmia was 1–180 days with a median of 10 (6, 20) days (median and interquartile range). Of the 277 subjects, 148 (53.4%) had ageusia; 15 subjects (5.4%) experienced anosmia as the only symptom, and 12 subjects (4.33%) developed ageusia as the only symptom. Of all the symptomatic subjects with anosmia 162 (58.5%), and 76 (41.36%) subjects reported a subjective impact on quality of life. Conclusion: More than half of the COVID-19 patients in the study presented with anosmia that was transient in the majority of cases.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed272    
    Printed14    
    Emailed0    
    PDF Downloaded37    
    Comments [Add]    

Recommend this journal